Reimagining Druggability

We are reimagining druggability using chemoproteomic platforms to develop transformative medicines.

Explore more

Our
Research

One of the greatest challenges that we face in discovering new disease therapies is that most proteins are considered “undruggable.” Our research group is reimagining druggability by using chemoproteomic approaches to tackle the undruggable proteome.

Meet Our Team

We are a group of highly motivated scientists with a desire to engage in multidisciplinary research at the interface of chemistry and biology.

Latest News

VIEW ALL NEWS
— NEWS

Our paper on DUBTACs for targeted protein stabilization is now out!!

Congrats to co-first authors Nate Henning and Lydia Boike! https://www.nature.com/articles/s41589-022-00971-2.pdf
— NEWS

Excited to present our newest discovery on the Deubiquitinase Targeting Chimera Platform for Targeted Protein Stabilization

Excited to share the newest discovery and BioRxiv preprint from our Novartis-Berkeley Center for Proteomics and Chemistry Technologies on the development of a new induced…
— NEWS

Congrats to chemical biology graduate student Nate Henning for passing his qualifying exam!

Congrats to chemical biology graduate student Nate Henning for passing his qualifying exam!!
— NEWS

Congrats to chemical biology graduate student Bridge Belcher for passing her qualifying exam!

Congrats to chemical biology graduate student Bridge Belcher for passing her qualifying exam!

Help us advance
our research